Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
NHSBT Clinical Biotechnology Centre (CBC) has an MHRA licence for the manufacture of sterile investigational medicinal gene therapy and recombinant protein products for clinical trials. The intended use of the reagents is for the GMP production of these types of products in manufacturing processes.
No supplier information available.
This procurement was divided into 1 lots, each awarded separately.
| Lot | Value | Status |
|---|---|---|
| Lot 1 | - | planned |